Osteofibrous Dysplasia (Kempson-Campanacci's Disease)

Completed

• Conditions: Osteofibrous Dysplasia

• Registration Number: NCT04104763
• Lead Sponsor: Istituto Ortopedico Rizzoli

Brief Summary

The aim of the present study is to obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-08-08
• Study First Submitted: 2019-09-24
• Study First Submitted QC: 2019-09-24
• Study First Posted: 2019-09-26
• Primary Completion: 2019-11-30
• Status Verified: 2021-08
• Study Completion: 2021-09-30
• Last Update Submitted: 2022-08-22
• Last Update Posted: 2022-08-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Male and female patients treated at Rizzoli Institute from 01 Jan 1943 to 31 Dic 2011
• Diagnosis of osteofibrous dysplasia pathologically confirmed
• Written informed consent prior to any study-specific analysis and/or data collection

Exclusion Criteria

• Patients with histological diagnosis different from osteofibrous dysplasia

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Osteofibrous Dysplasia (Kempson-Campanacci's disease): Long Term Follow-up Study on Natural History, Results of Treatment and Relationship with Adamantinoma	BASELINE	We will retrieve from the database of the Rizzoli institute all the cases with a histological diagnosis of Ewing sarcoma from 01 Jan 1943 to 31 Dic 2011.; We aspect to find approximately 55 cases. We will review all the medical records, radiological imaging, and histological data of these cases.

Trial Locations

Locations (1)

Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli; 🇮🇹 Bologna, Italy